Wu et al. conducted a phase-II clinical trial investigating the effectiveness of multiple doses of erythropoietin (EPO) administered with hypothermia on neuroradiographic and neurodevelopment of 24 newborns with HIE (28). Here, EPO is linked to perinatal asphyxia.